Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "amgen rank"

Amgen updates on Prolia in postmenopausal osteoporosis16-09-2014
Pharma Letter

Amgen Posts Results from Exploratory Analyses Evaluating Long-...

According to a release from the Company, Prolia is the first approved therapy that specifically targets RANK Ligand, an essential regulator of bone-removing cells (osteoclasts). Data were presented at the American Society for Bone and Mineral ... Individual.com, 1 month ago
[x]  

2 images for "amgen rank"

Scottrade, 2 months ago
Rediff.com, 3 months ago
Nasdaq

Amgen Upgraded to Strong Buy

On Aug 21, Zacks Investment Research upgraded Amgen Inc. ( AMGN ) to a Zacks Rank #1 (Strong Buy). Why the Upgrade? Amgen came out with strong second quarter results and an improved outlook for 2014 on Jul 29. The biotech company's earnings ...
 Yahoo! Finance1 month ago Zacks Rank #1 Additions for Wednesday - Tale of the Tape  Benzinga.com1 month ago Stock of the Week: Amgen Inc. (AMGN)  Nasdaq2 weeks ago Amgen Upgraded to Strong Buy - Analyst Blog  Zacks.com1 month ago
Seeking Alpha

Shares of Amgen Rank the Lowest in Terms of Projected Earnings Growth in the Biotechnology Industry (AMGN, SCLN, REGN, CELG, PDLI)

(Comtex SmarTrend(R)) Below are the three companies in the Biotechnology industry with the lowest projected earnings growth. The growth of earnings per share (current fiscal year estimated vs. last year actual) is important to gauge future ...
 Individual.com2 months ago Shares of Vertex Pharmaceuticals Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (VRTX, PDLI, AMGN, ALKS, MDVN)  Comtex SmarTrend4 weeks ago Shares of Repligen Rank the Lowest in Terms of EBITDA Growth in the Biotechnology Industry (RGEN, PCYC, MYGN, ACOR, AMGN)  Comtex SmarTrend1 month ago Shares of Biogen Idec Rank the Highest in Terms of Free Cash Flow Per Share in the Biotechnology Industry (BIIB, UTHR, AMGN, REGN, CELG)  Comtex SmarTrend1 month ago
[x]  
Nasdaq

Ligand Inks 2nd Captisol Deal with CURx Pharmaceuticals - Analyst Blog

Ligand Pharma holds a Zacks Rank #3 (Hold). A better-ranked stock in the biotech sector is Amgen Inc., which carries a Zacks Rank #1
 Nasdaq1 month ago

Daniel Loeb urges Amgen to split into two companies

(REUTERS) Hedge fund manager Daniel Loeb told investors on Tuesday he urged U.S. biotechnology company Amgen Inc to split into two separate businesses, a move he said could boost its share price by more than 80 percent. Our own extensive ...
 Fortune8 hours ago UPDATE 2-Third Point's Loeb urges breakup of biotech company Amgen  CNBC8 hours ago Loeb's hedge fund Third Point bets on eBay, Amgen, Alibaba, exits Sony  GlobalPost8 hours ago Third Point's Loeb urges breakup of biotech company Amgen  Yahoo! Finance8 hours ago

Amgen Sues Sanofi and Regeneron over PCSK9 Candidate

Amgen Inc. ( AMGN ) has filed a lawsuit against Sanofi ( SNY ) and Regeneron Pharmaceuticals, Inc. ( REGN ) in the U.S. District Court of Delaware. The lawsuit is related to the infringement of certain patents (patent numbers 8,563,698, 8,829,165, ...
 Yahoo! Finance1 day ago

The Zacks Analyst Blog Highlights: Auxilium, Gilead, AbbVie, Amgen and Alnylam

For Immediate Release Chicago, IL October 16, 2014 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
 Yahoo! Finance5 days ago The Zacks Analyst Blog Highlights:Auxilium, Gilead, AbbVie, Amgen and Alnylam  MoneyShow.com5 days ago THE ZACKS ANALYST BLOG HIGHLIGHTS : Auxilium, Gilead, AbbVie, Amgen and Alnylam  4 Traders5 days ago
[x]  

Amgen's Blinatumomab Gets Priority Review in the U.S.

Investors in the pharma/biotech sector eagerly wait for pipeline updates as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an ...
 Yahoo! Finance1 week ago Synthetic Biologics' SYN-005 Gets Orphan Drug Designation  Yahoo! Finance1 month ago
[x]  

Amgen's Data on Evolocumab Published in The Lancet

Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight ...
 Yahoo! Finance1 week ago Amgen Seeks EU Approval for PCSK9 Inhibitor Evolocumab  Yahoo! Finance1 month ago Merck Posts Positive Data on Osteoporosis Drug Odanacatib  Yahoo! Finance1 month ago
[x]  

Amgen Up on Positive Phase III Data on Psoriasis Biosimilar

Amgen Inc. ( AMGN ) was up almost 3% on encouraging top-line data from a phase III study on its biosimilar candidate, ABP 501. The randomized, double-blind, active-controlled study compared the safety and efficacy of ABP 501 to AbbVie Inc.'s ( ABBV ...
 Yahoo! Finance1 week ago Sanofi Reports Positive Phase III Data on Dengue Vaccine  Yahoo! Finance1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less